JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puig, M. M.
Right arrow Articles by Pol, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puig, M. M.
Right arrow Articles by Pol, O.

Vol. 287, Issue 3, 1068-1075, December 1998

Peripheral Effects of Opioids in a Model of Chronic Intestinal Inflammation in Mice1,2

Margarita M. Puig and Olga Pol

Anesthesiology Research Unit, IMIM, Department of Anesthesiology, Hospital Universitario del Mar, Barcelona, Spain

The study describes a model of chronic intestinal inflammation in mice. Inflammation was induced by the administration of one dose of croton oil (CO) (acute CO) or two doses (chronic CO) of intragastric CO, whereas controls received saline (SS); GI transit was measured with charcoal. Chronic CO induced intestinal inflammation substantiated by optical microscopy, weight loss (20%) and a 25% increase in GI transit. The ED50 values in SS animals were 1.67 ± 0.13 mg/kg for morphine and 0.038 ± 0.006 mg/kg for fentanyl; chronic CO significantly decreased the ED50 values to 0.16 ± 0.03 mg/kg (morphine) and 0.006 ± 0.0005 mg/kg (fentanyl). Thus the potency of morphine increased 10.4 times and that of fentanyl 6.3 times. The effects of enkephalin, but not those of U-50488H, were also significantly enhanced during chronic CO. The antitransit effects of p.o. loperamide increased 11.7 times during chronic CO. All effects were reversed by specific antagonists. The fraction of the active opioid receptor that mediates the antitransit effects of morphine was evaluated using beta -funaltrexamine. In chronic CO, the doses of beta -funaltrexamine needed to antagonize 1 mg/kg of morphine were significantly higher than in SS and acute CO, and the ED50/KA ratio was 20 times lower. These results suggest an increase in the active concentration of µ-opioid receptors during chronic inflammation.

0022-3565/98/2873-1068$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Interv.Home page
V. Petrovic, S. Teng, and M. Piquette-Miller
REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION
Mol. Interv., April 1, 2007; 7(2): 99 - 111.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D Philippe, D Chakass, X Thuru, P Zerbib, A Tsicopoulos, K Geboes, P Bulois, M Breisse, H Vorng, J Gay, et al.
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation
Gut, June 1, 2006; 55(6): 815 - 823.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y. S. Andersen, F. D. Gillin, and L. Eckmann
Adaptive Immunity-Dependent Intestinal Hypermotility Contributes to Host Defense against Giardia spp.
Infect. Immun., April 1, 2006; 74(4): 2473 - 2476.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Jimenez, M. M. Puig, and O. Pol
Antiexudative Effects of Opioids and Expression of {kappa}- and {delta}- Opioid Receptors during Intestinal Inflammation in Mice: Involvement of Nitric Oxide
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 261 - 270.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Li, P. Zhou, and S. M. Singer
Neuronal Nitric Oxide Synthase Is Necessary for Elimination of Giardia lamblia Infections in Mice
J. Immunol., January 1, 2006; 176(1): 516 - 521.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. S. Kimball, J. M. Palmer, M. R. D'Andrea, P. J. Hornby, and P. R. Wade
Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice
Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1266 - G1273.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
O. Pol, J. R. Palacio, and M. M. Puig
The Expression of {delta}- and {kappa}-Opioid Receptor Is Enhanced during Intestinal Inflammation in Mice
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 455 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
O. Pol, F. Alameda, and M. M. Puig
Inflammation Enhances {micro}-Opioid Receptor Transcription and Expression in Mice Intestine
Mol. Pharmacol., November 1, 2001; 60(5): 894 - 899.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Valle, O. Pol, and M. M. Puig
Intestinal Inflammation Enhances the Inhibitory Effects of Opioids on Intestinal Permeability in Mice
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 378 - 387.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.